Related Experiment Video
Updated: Jul 15, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Convergent TP53 loss and evolvability in cancer
Marcela Braga Mansur1, Mel Greaves2
1Centre for Evolution and Cancer, The Institute of Cancer Research, ICR, London, UK.
Cancer evolution involves natural selection, leading to diverse mutations. The TP53 gene frequently shows functional loss variants, indicating convergent evolution in cancer development and drug resistance.
Area of Science:
- Oncology
- Evolutionary Biology
- Genomics
Background:
- Cancer cell populations exhibit significant mutational diversity within and between patients.
- Understanding cancer evolution is crucial for developing effective therapies.
- The role of specific genes, like TP53, in cancer evolution requires further investigation.
Purpose of the Study:
- To explore the evolutionary trajectories of cancer cell populations.
- To investigate whether cancer evolution exhibits repetitive or predictable patterns.
- To examine the significance of TP53 gene variants in cancer evolution and drug resistance.
Main Methods:
- Genomic scrutiny of patient samples.
- Analysis of mutational profiles.
- Discussion of microenvironmental selective pressures and TP53 gene variants.
Main Results:
- Cancer evolution is a stepwise process driven by natural selection within a tissue ecosystem.
- Extraordinary diversity in mutational profiles is observed in cancer patients.
- Functional loss variants in the TP53 gene are the most common genetic alteration in cancer, suggesting convergent evolution.
Conclusions:
- Cancer evolution displays convergent patterns, particularly concerning TP53 gene mutations.
- Microenvironmental selective pressures significantly impact cancer cell fitness and evolvability.
- TP53 alterations are linked to increased probability of subsequent drug resistance.
More Related Videos
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

